Orally Administered Corticosteroid Compositions

Patent No. EP2482822 (titled "Orally Administered Corticosteroid Compositions") was filed by Adare I on Sep 30, 2010. The application was issued on Aug 1, 2018.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
DR FALK PHARMAMar 1, 2019LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2482822

ADARE I
Application Number
EP10821232A
Filing Date
Sep 30, 2010
Status
Revoked
Jul 29, 2022
Publication Date
Aug 1, 2018